Medipass is a specialist provider of advanced medical equipment solutions. Medipass works with and supports hospitals to provide great patient care. The history, skill sets and our approach to working with hospitals is unique and, our solutions enhance patients’ experiences, reduce costs and increase efficiencies.

About Medipass

Clinically led, founded by a neurologist with five physicians on staff.

Why it matters

Being clinically led helps us understand what is important to physicians and
other clinicians and provides insight into the clinician’s point of view when it
comes to selecting and managing high value advanced medical equipment.

About Medipass

The longest established (founded 1995) international vendor independent MES provider in Europe.

Why it matters

Being international and the longest established provides unrivalled insight into
hospital strategies and international pricing across a spectrum of equipment
modalities regarding high value advanced medical equipment (including linacs, tomotherapy, cyberknife, CT, MRI, ultrasound and other radiotherapy and
imaging related equipment).

About Medipass

Vendor neutral.

Why it matters

Vendor independence means that Medipass will always suggest the right
equipment at the right time for the clinical needs of the hospital. Medipass is not
a seller of equipment or an OEM (e.g. Varian, Siemens, Elekta, GE, Phillips,
Toshiba, Accuray), so it is not motivated by the sale of equipment to the hospital.
This means the decision to extend the life of a piece of equipment is based on the equipment in question and the clinical strategy of the department. Being vendor independent also means that Medipass spends a portion of its time and energy managing the OEMs. Focusing on the OEM deliverables often means improved performance by the OEM and, accordingly, of the equipment.

   

About Medipass

  • Strong financially; our immediate parent company is KOS and our ultimate
    parent company is CIR.
  • KOS annual turnover 2014 was €392m.
  • KOS focus is on healthcare and advanced medical technology services.
  • KOS manages circa 5,500 non-acute care beds in over 83 facilities and has over 4500 employees.
  • CIR annual turnover 2014 over $5.2bn.
  • CIR has five business sectors:  Media; Healthcare; Automotive
    Components; and Finance.

Why it matters

Financial strength is important in that it shows the ability of the MES provider
(and its parent company, if a guarantor) to stand behind the MES contract;
financial strength facilitates competitive finance terms from banks; financial
strength is an indicator of the operation of the company generally; financial wherewithal facilitates the completion of projects that may be delayed or may
not otherwise happen.

About Medipass

The largest MES specialist team in the industry with circa 100 specialist
employees dedicated solely to the management of high value advanced
medical equipment.

Why it matters

A large specialist team means that Medipass is ideally suited to provide an
efficient and effective managed equipment service and provides the wherewithal to handle equipment related challenges that may arise during the term of the MES; it also means that becauseof such broad and deep knowledge, Medipass can become a “Trusted Advisor” to the hospital as it faces and works though equipment related challenges.

About Medipass

Member of the winning consortium for the proton therapy service in Mestre, Italy.

Medipass is part of the design team and has provided ground-breaking patient
flow and design ideas.

Medipass will, upon completion of the proton centre, operate the facility (except
for clinical and building FM) and manage the proton centre’s medical equipment.

Why it matters

Being instrumental in the development of one of the latest proton therapy
projects provides Medipass with unrivalled experience in the advanced treatment of cancer. The experience and lessons learned in this project will be imbedded in the Medipass team, which may be of assistance to the hospital in its imaging and radiotherapy initiatives and its goal to providing the most advanced imaging and radiotherapy care to its patients.

About Medipass

Strong working relationships with hospitals and equipment manufacturers.

Why it matters

Strong working relationships are required in complex projects involving the
treatment of patients with high value advanced medical equipment. It is almost inevitable that challenges will arise; it is crucial to the success of the project that
the MES provider, OEM and the hospital work together in partnership. Having
strong established relationships help to resolve issues faster and more efficiently.

About Medipass

Extensive NHS understanding and experience, including in NHS imaging and radiotherapy managed equipment initiatives.

Why it matters

Significant NHS experience means that Medipass understands the needs and objectives of the NHS and understands the challenging times and significant
changes that NHS Trusts are currently going through (e.g. QIPP).
This understanding and empathy will help to develop the working relationship
between the hospital and Medipass. Uniquely, Medipass has experience of
working with and within the NHS and with private sector hospitals. This combined experience means that Medipass has wide experience and can bring best ideas from private practice to the NHS and vice versa.

About Medipass

Medipass has a series of “Firsts” in the management of high value advanced
medical equipment.

  • First Managed Equipment Service contract for an MRI facility Italy - 1996
  • First Managed Equipment Service in Nuclear Medicine-PET - 2001
  • First FDG network among 3 public hospitals (Castelfranco – Venice/Mestre - Vicenza)
  • First PET-CT in an Italian public hospital (Venice/Mestre) - 2002
  • First PET Education Centre for University Hospitals (Udine, Padua, Veneto Onchologic Institute), and Rovigo Public Hospital
  • First PET Center (with Radiopharmacy and Cyclotron) in Rome - 2005
  • First sponsor of Proton Therapy Centre in Italy 2011
  • First Managed Equipment Service in India – 2010
  • First installation of IMRT linear accelerator to the Hissar region, India (the first  IMRT serving a population of over 7 million people)
  • First to be installed linear accelerator to Nanded region, India (the first linear accelerator serving a population of over 5 million people).

Why it matters

Being first is a sign of innovation and, for Medipass, shows its willingness to work with and support hospitals in developing new clinical services for the benefit of patients. Developing new services, in new areas, as Medipass has done in various markets in collaboration with its client hospitals, has the benefit of energising and motivating the hospital clinical and non-clinical staff and the employees of Medipass as well. In turn, the patients and general community surrounding the hospital benefit as well.